1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

22Aug/13

Have illness, will travel: Where and why Canadians travel for specialized … – MetroNews Canada

August 22, 2013Transplantationadmin

Have illness, will travel: Where and why Canadians travel for specialized …MetroNews CanadaPatients from New Brunswick, Newfoundland and P.E.I. will go to the Atlantic Canada Multi-Organ Transplant Program at the Queen Elizabeth II Health Sciences Ce…

22Aug/13

Hand transplantation: A Swiss research success – Medical Xpress

August 22, 2013Other Transplantationadmin

Hand transplantation: A Swiss research success
Medical Xpress
The successful research trio (from left): Robert Rieben, Esther Vögelin and Thusitha Gajanayake. Credit: Tanja Kocher. Hope for hand amputees: researchers at Inselspital and the University of Bern have successfully tested a new method for local …

22Aug/13

Biggest heart attack risks for Indians revealed – Times of India

August 22, 2013Heartadmin

Times of IndiaBiggest heart attack risks for Indians revealedTimes of IndiaIndian researchers have conducted a data mining exercise to find out important risk factors in increasing the chances of an individual having a heart attack. The authors confirm…

22Aug/13

EECP – a cheaper, non invasive treatment for heart disease – India.Com Health

August 22, 2013Heartadmin

EECP – a cheaper, non invasive treatment for heart disease
India.Com Health
In what could perhaps be one of the most effective ways of treating heart diseases, a non-invasive procedure—enhanced external counter pulsation (EECP)—is poised to be the next big medical offing in the state. While traditional medication for heart …

and more »

22Aug/13

Biocad enters deal for exporting rituximab biosimilar to Turkey – The Pharma Letter

August 22, 2013Monoclonal Anti-CD20 Antibodiesadmin

Biocad enters deal for exporting rituximab biosimilar to Turkey
The Pharma Letter
Biocad, one of Russia’s leading biotechnology companies, has signed a definitive agreement on the export of rituximab active pharmaceutical ingredients (APIs) produced by the company with Kocak Farma, a leading Turkish drugmaker with strong presence …

22Aug/13

What are the biggest heart attack risks for Indians? – India.Com Health

August 22, 2013Heartadmin

What are the biggest heart attack risks for Indians?India.Com HealthIndian researchers have conducted a data mining exercise to find out important risk factors in increasing the chances of an individual having a heart attack. High blood cholesterol, in…

22Aug/13

Illumina Introduces New Reagent Kits for the MiSeq System – HispanicBusiness.com

August 22, 2013HLA Typingadmin

Illumina Introduces New Reagent Kits for the MiSeq System
HispanicBusiness.com
The benefits of increased paired-end read lengths include improving the quality of genome assemblies and advancing applications that require longer read lengths, such as metagenomics and human leukocyte antigen (HLA) typing. “The new MiSeq kits are …

21Aug/13

Shark Antibodies: Bigger Than Jaws – Genetic Engineering News

August 21, 2013Antibodiesadmin

Shark Antibodies: Bigger Than JawsGenetic Engineering NewsSharknado and other popular shark movies aside, a unique type of antibody molecule from this ancient species is providing insights into the evolution of the adaptive immune system. These antibod…

21Aug/13

UC Davis Develops New Strategy Tests for Dangerous Stage of Tuberculosis in … – San Francisco Chronicle (press release)

August 21, 2013Lungadmin

UC Davis Develops New Strategy Tests for Dangerous Stage of Tuberculosis in …San Francisco Chronicle (press release)At least 600 million people in Pakistan, India and Bangladesh are infected with the tuberculosis bacterium Mycobacterium tuberculosis….

21Aug/13

New hepatitis C treatment receives Pharmac funding – New Zealand Doctor Online

August 21, 2013Transplantationadmin

New hepatitis C treatment receives Pharmac funding
New Zealand Doctor Online
“In New Zealand, hepatitis C cirrhosis is now the leading cause of liver cancer and liver failure and is the leading indication for liver transplantation. By offering a better chance of a cure, we can prevent progression to cirrhosis, thereby reducing …

and more »

Posts navigation

  • « Previous
  • 1
  • …
  • 15,689
  • 15,690
  • 15,691
  • 15,692
  • 15,693
  • …
  • 18,296
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos